🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Shanghai
Clinical trial register · China

Clinical Trials in Shanghai, 2026

Every study on the ClinicalTrials.gov registry that lists a site in China and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 19052 matching records held by the registry are in this view. Synced 22 Sep 2026, 11:10 UTC
19052
Studies in scope
all four open statuses
11786
Recruiting now
open to new participants
2009
Lead sponsors
across recruiting studies
Top sites
Shanghai 72 Fuzhou 5 Guangzhou 4 Changchun 3 Suzhou 3
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Fudan University454 Ruijin Hospital276 Shanghai Zhongshan Hospital163 RenJi Hospital135 Children's Hospital of Fudan University84 Clear sponsor filter
Site location
Shanghai72 Fuzhou5 Guangzhou4 Changchun3 Suzhou3
All 38 locations
Target enrolment
to

Trials with a site in Shanghai

72 of 19052 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Chinese sites
Start
Not yet open
Circadian-Synchronized Breast Milk Feeding and Sleep in Preterm Infants: A Multicenter Randomized Controlled Trial
NCT07645677Preterm Infant, Sleep
Shanghai Jiao Tong University School of Medicine
Not applicable
120
Fuzhou, Nantong, Shanghai, Zhangjiagang
2026-09-01
Recruiting
Neoadjuvant Pyrotinib-to-pertuzumab in HER2+ eBC
NCT07797218Breast Cancer Early Stage Breast Cancer (Stage 1-3)
DrugsPyrotinib·Pertuzumab·Trastuzumab·Docetaxel
Shanghai Jiao Tong University School of Medicine
Phase 3
220
Shanghai
2026-07-01
Recruiting
Oral Health, Saliva Bacteria, and Disease Activity in Children With JIA: A Cross-Sectional Study.
NCT07799831Juvenile Idiopathic Arthritis
Shanghai Jiao Tong University School of Medicine
Observational
200
Shanghai
2026-07-01
By invitation
Organoid-based Sensitivity-guided Chemotherapy for Advanced / Refractory Pediatric Tumors
NCT07528079Soft Tissue Sarcoma, Child
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2026-04-01
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Untreated Peripheral T-Cell Lymphoma
NCT07535762Peripheral T-Cell Lymphoma (PTCL NOS), Nodal T-follicular Helper Cell Lymphoma, Anaplastic Large Cell Lymphoma (ALCL) (ALK-1 Negative)
DrugsAclarubicin·Vincristine·Prednisone·Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 2
36
Shanghai, Wuxi
2026-03-30
Not yet open
Aclarubicin Plus Cyclophosphamide, Vincristine, and Prednisone (CAOP) in Patients With Previously Treated Cutaneous T-cell Lymphoma
NCT07535710Cutaneous T-Cell Lymphoma Refractory, Cutaneous T-Cell Lymphoma, Relapsed, Sezary Syndrome, Cutaneous T Cell Lymphoma (CTCL)
DrugsAclarubicin·Vincristine·Prednisone·Cyclophosphamide
Shanghai Jiao Tong University School of Medicine
Phase 1/2
37
Shanghai, Wuxi
2026-03-30
Not yet open
Aclarubicin Plus With Azacitidine and Venetoclax in the Treatment of Acute Myeloid Leukemia
NCT07486726Acute Myeloid Leukemia (AML), Relapse Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia (AML)
DrugsAclarubicin·Azacitidine·Venetoclax
Shanghai Jiao Tong University School of Medicine
Phase 1/2
112
Shanghai
2026-03-15
Recruiting
Neoadjuvant Trastuzumab Deruxtecan (SHR-A1811) + Pertuzumab in HER2+ Breast Cancer
NCT07393425HER2 + Breast Cancer
DrugsPyrotinib·Pertuzumab·Trastuzumab deruxtecan·Trastuzumab
Shanghai Jiao Tong University School of Medicine
Phase 2
50
Shanghai
2026-02-02
Recruiting
Early Myocardial Dysfunction Helps Identify Severe Refractory Pediatric Lupus
NCT07425730Systemic Lupus Erythematosus (SLE)
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2026-02-01
Recruiting
Support System Design for Adolescent Scoliosis Orthosis Wear
NCT07574229Adolescent Idiopathic Scoliosis (AIS), Adherence
Shanghai Jiao Tong University School of Medicine
Not applicable
18
Shanghai
2026-02-01
Recruiting
CS-121 APOC3 Base Editing in Children and Adolescents With Hyperchylomicronemia
NCT07371767Hyperchylomicronemia
DrugCS-121
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
15
Shanghai
2026-01-26
Recruiting
Multicenter, Phase II Clinical Study of Sacituzumab Tirumotecan (Sac-TMT) in Combination With KL-A167 for Neoadjuvant Treatment of Triple-Negative Breast Cancer
NCT07371208Breast Cancer
DrugSacituzumab tirumotecan
Shanghai Jiao Tong University School of Medicine
Phase 2
40
Shanghai
2025-12-24
Recruiting
Multi-center Randomized Controlled Clinical Study of Shenling Baishu Granule to Prevent the Recurrence of Low-risk Colorectal Adenoma
NCT06930157Low-risk Colorectal Adenoma
Shanghai Jiao Tong University School of Medicine
Phase 4
624
Shanghai
2025-11-24
Not yet open
Evaluation of the Efficacy and Safety of Magnetically-controlled Capsule Gastroscopy for Postoperative Assessment in Elderly Patients and Patients With Underlying Diseases
NCT06029608Evaluation,Efficacy,Safety
Shanghai Jiao Tong University School of Medicine
Observational
120
Shanghai
2025-11-06
Not yet open
Multi-omics Study of Peritoneal Dialysis Effluent to Explore Biomarkers of Peritoneal Fibrosis
NCT07208513Peritoneal Dialysis, Peritoneal Fibrosis
Shanghai Jiao Tong University School of Medicine
Observational
55
Shanghai
2025-10-20
Not yet open
Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)
NCT07047352Carbapenem-resistant Enterobacterales, Neutropenia, Hematological Malignancies
Shanghai Jiao Tong University School of Medicine
Not applicable
91
Shanghai
2025-08-01
Recruiting
Shanghai Clinical Cohort - Adrenal Disease
NCT07191951Adrenal Disease
Shanghai Jiao Tong University School of Medicine
Observational
600
Shanghai
2025-07-25
Recruiting
Standardized Implementation and Quality Assessment System for Confocal Enteroscopy
NCT07363291Confocal Enteroscopy, Quality Assessment System, Standardized Implementation
Shanghai Jiao Tong University School of Medicine
Observational
600
Hefei, Ningbo, Kashgar, Shanghai
2025-06-01
Recruiting
XP-005 Personalized Vaccine Alone or in Combination With Toripalimab for the Prevention of Relapse After Remission in Acute Myeloid Leukemia
NCT06980155Acute Myeloid Leukemia
DrugPersonalized neoantigen tumor vaccine
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
60
Shanghai
2025-05-30
Recruiting
Research on Early Prediction Model of Ischemic Cerebrovascular Disease Based on Artificial Intelligence Technology.
NCT06978348Ischemic Cerebrovascular Disease, Artificial Intelligence, Prediction Model
Shanghai Jiao Tong University School of Medicine
Observational
244,296
Shanghai
2025-05-10
Active, closed
A Randomized Controlled Trial of Robotic Support for Enhanced Later Life (RoSELL)
NCT07102017Loneliness, Well-Being, Psychological, Depression - Major Depressive Disorder
Shanghai Jiao Tong University School of Medicine
Not applicable
90
Shanghai
2025-05-06
Not yet open
Electronic Blood Pressure Monitor for Atrial Fibrillation Detection
NCT06931288Atrial Fibrillation (AF)
Shanghai Jiao Tong University School of Medicine
Not applicable
20,000
Shanghai
2025-05-06
Active, closed
Gamified Digital Balance Assessment
NCT07088848Disease Prevention
Shanghai Jiao Tong University School of Medicine
Not applicable
30
Shanghai
2025-04-20
Not yet open
Standardized Antihypertensive Treatment Protocol
NCT06790927Hypertension
Shanghai Jiao Tong University School of Medicine
Not applicable
400
Shanghai
2025-02-24
Not yet open
Identification of Pathogenic Bacteria of Diabetes Foot Ulcer
NCT06777810Diabetic Foot Disease, Diabetic Foot Ulcer, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
60
Shanghai
2025-01-31
Recruiting
Clinical Evaluation of Non-invasive Blood Glucose Meter
NCT06796322Diabetes Mellitus
Shanghai Jiao Tong University School of Medicine
Not applicable
210
Shanghai
2025-01-01
Recruiting
Study Comparing Reduced Versus Standard Dose Post-transplantation Cyclophosphamide in Combination With Post-engraftment Anti-thymoglobin as Graft Versus Host Disease Prophylaxis in Alternative Donor Peripheral Stem Cell Transplantation
NCT06705062Allogeneic Hematopoietic Cell Transplant, Graft Versus Host Disease
Shanghai Jiao Tong University School of Medicine
Phase 3
316
Shanghai
2025-01-01
Recruiting
Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC
NCT06500208Breast Cancer
DrugAdebrelimab
Shanghai Jiao Tong University School of Medicine
Phase 2
48
Shanghai
2024-11-01
Recruiting
GzmB-PET/CT to Evaluate Neoadjuvant Therapy Efficacy in Breast Cancer
NCT06725940Breast Cancer Invasive
Shanghai Jiao Tong University School of Medicine
Observational
50
Shanghai
2024-11-01
Active, closed
Predictive Analysis of Diabetic Foot Ulcer
NCT06768554Diabetic Foot Ulcer (DFU), Diabetic Foot Disease, Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
2,000
Shanghai
2024-10-31
Active, closed
Phase II Study of Sonrotoclax Combined With Chemotherapy in the Treatment of Newly Diagnosed Acute Myeloid Leukemia
NCT06497062Acute Myeloid Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2
47
Shanghai
2024-10-30
Recruiting
Evaluation of the Safety, Tolerability, and Efficacy of LE051 in Patients With Duchenne Muscular Dystrophy
NCT06900049Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
12
Shanghai
2024-10-24
Recruiting
6-year Follow-up Data After the Berberine Intervention Trial
NCT06629051Colorectal Adenoma, Colorectal Cancer Control and Prevention, Colorectal Polyps
Shanghai Jiao Tong University School of Medicine
Observational
891
Shanghai
2024-10-04
Recruiting
Magnetic Seizure Therapy for Psychotic Disorders
NCT06581302Psychotic Disorders
Shanghai Jiao Tong University School of Medicine
Not applicable
50
Shanghai
2024-09-01
Active, closed
A Clinical Study for the Treatment of Pediatric and Adolescent Patients With Type 1 Gaucher Disease
NCT06528080Gaucher Disease
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
3
Shanghai
2024-08-01
Recruiting
Evaluation of the Safety and Efficacy of BBM-D101 to Treat Patients with Duchenne Muscular Dystrophy
NCT06641895Duchenne Muscular Dystrophy (DMD)
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
6
Shanghai
2024-07-25
Active, closed
Open, Randomized Crossover Study on PK, PD, Biopotency, and Bioavailability of Insulin Capsules in Healthy Chinese Males
NCT06519604Diabete Mellitus
DrugHuman Insulin
Shanghai Jiao Tong University School of Medicine
Phase 1
20
Shanghai
2024-07-17
Recruiting
Efficacy Study of Blinatumomab Clean Up Early Residual Disease for Newly Diagnosed Pediatric B Lymphoblastic Leukemia
NCT06607419B-Cell Lymphoblastic Leukemia
DrugBlinatumomab
Shanghai Jiao Tong University School of Medicine
Phase 2/3
90
Hefei, Fuzhou, Shanghai, Ningbo
2024-05-21
Recruiting
ctDNA in HER2+ EBC Neoadjuvant Treatment
NCT07335081Breast Cancer
DrugsPyrotinib·Pertuzumab·Trastuzumab·Docetaxel
Shanghai Jiao Tong University School of Medicine
Phase 2
60
Shanghai
2024-02-01
Recruiting
Treatment of Advanced Endocrine Tumor With Iindividualized mRNA Neoantigen Vaccine (mRNA-0523-L001)
NCT06141369Adrenal Cortical Carcinoma, Medullary Thyroid Cancer, Thymic Neuroendocrine Carcinoma, Pancreatic Neuroendocrine Tumor
Shanghai Jiao Tong University School of Medicine
Not applicable
21
Shanghai
2024-01-13
Recruiting
Atrophic Gastritis Predicts the Risk of Gastric Cancer
NCT06203327Atrophic Gastritis
Shanghai Jiao Tong University School of Medicine
Observational
2,042
Shanghai
2023-12-15
By invitation
National Multicenter Registry for Pediatric End-Stage Heart Failure in China
NCT06927440Heart Failure, Children
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2023-12-01
Recruiting
Conditioning Regimen of Melphalan-busulfan and Fludarabine: a Randomized Study of Different Dose of Melphalan
NCT06829472Toxicities, Survivorship
DrugMelphalan
Shanghai Jiao Tong University School of Medicine
Phase 3
120
Shanghai
2023-12-01
Recruiting
Short-course Trastuzumab, Pertuzumab with Taxanes in the Adjuvant Treatment of Early HER2-positive Breast Cancer
NCT05891561Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 2
120
Shanghai
2023-11-01
Recruiting
Randomized Study of Conditioning of Fludarabine Combined With Single or Dual Alkylating Agents in Myeloid Malignancies
NCT05991908Acute Myeloid Leukemia, Myelodysplastic Syndromes
DrugFludarabine and Busulfan
Shanghai Jiao Tong University School of Medicine
Phase 3
222
Fuzhou, Xiamen, Nanning, Nanjin, Suzhou, Shanghai, Kunming
2023-10-19
Recruiting
Doxycycline for Helicobacter Pylori Rescue Treatment
NCT05874570Helicobacter Pylori Infection
DrugsBismuth potassium citrate·Metronidazole·Doxycycline·Tetracycline
Shanghai Jiao Tong University School of Medicine
Phase 4
368
Shanghai
2023-06-20
Active, closed
MRD in High-risk EBC
NCT06566729Breast Cancer
Shanghai Jiao Tong University School of Medicine
Observational
125
Shanghai
2023-06-01
Recruiting
Treatment of Chidamide and Venetoclax for Retinoic Acid and Arsenic Resistant Acute Promyelocytic Leukemia
NCT05881265APL
Shanghai Jiao Tong University School of Medicine
Phase 2
30
Huai'an, Nanchang, Shanghai, Guangzhou
2023-05-15
Recruiting
Autoimmune Hepatitis Cohort in China
NCT05785793Autoimmune Hepatitis
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2023-02-01
Recruiting
Chemotherapy CLAGE-Ven Sequential With Reduced Intensity Conditioning for Refractory Acute Myelodi Leukemia
NCT05870995Refractory Leukemia
Shanghai Jiao Tong University School of Medicine
Phase 2
100
Shanghai
2023-02-01
Recruiting
An Early Clinical Trial to Evaluate VGN-R09b for Treatment of Aromatic L-amino Acid Decarboxylase (AADC) Deficiency.
NCT05765981Aromatic L-amino Acid Decarboxylase (AADC) Deficiency
Shanghai Jiao Tong University School of Medicine
Phase EARLY_PHASE1
6
Shanghai
2023-01-30
Recruiting
Prospective National Multi-center Registry of Obstructive Sleep Apnea Syndrome in Hypertensive Patients in China
NCT05735444Hypertension, Obstructive Sleep Apnea
Shanghai Jiao Tong University School of Medicine
Observational
633
Shanghai
2023-01-01
Not yet open
Atherosclerotic Cardiovascular Risk in Childhood and Teen-age Onset Diabetes
NCT05294653Atherosclerotic Cardiovascular Disease, Childhood Diabetes Mellitus, Juvenile Diabetes
Shanghai Jiao Tong University School of Medicine
Observational
300
Shanghai
2022-06-01
Recruiting
Reduced MBF Regimen for Patients >=55 Years With Myeloid Malignancies
NCT05436561Disease-free Survival
Shanghai Jiao Tong University School of Medicine
Phase 2
61
Shanghai
2022-06-01
Recruiting
Neoadjuvant Anti-PD-1 and TP Versus TPF on Pathological Response in OSCC
NCT05125055Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1, Chemotherapy
Shanghai Jiao Tong University School of Medicine
Phase 2/3
80
Shanghai
2021-10-01
Recruiting
Renal Artery Fibromuscular Dysplasia Registry
NCT05363748Renal Artery Fibromuscular Dysplasia
Shanghai Jiao Tong University School of Medicine
Observational
500
Shanghai
2021-10-01
Recruiting
Neoadjuvant Personalized Anti-PD-1 and Anti-VEGFR Therapy in OSCC Patients
NCT05069857Oral Squamous Cell Carcinoma, Neoadjvant Therapy, Anti-PD-1, Anti-VEGFR
DrugsApatinib·Camrelizumab
Shanghai Jiao Tong University School of Medicine
Phase 2
46
Shanghai
2021-09-01
Recruiting
Precise Diagnosis, Treatment and Prognostic Evaluation of Complicated Adrenal Tumor Diseases
NCT04529629Complicated Adrenal Tumor Diseases
Shanghai Jiao Tong University School of Medicine
Observational
1,000
Shanghai
2021-08-30
Active, closed
Intensive Management of Blood Pressure and Cholesterol in Elderly Chinese With Hypertension and Atrial Fibrillation
NCT04111419Atrial Fibrillation, Hypertension
DrugAllisartan Isoproxil
Shanghai Jiao Tong University School of Medicine
Phase 4
1,200
Shanghai
2020-07-01
Recruiting
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
NCT04183712Gallbladder Carcinoma
DrugsGemcitabine and oxaliplatin·Afatinib
Shanghai Jiao Tong University School of Medicine
Phase 2
102
Shanghai
2020-06-01
Active, closed
Pyrotinib, Trastuzumab, Pertuzumab and Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
NCT04398914Breast Cancer Invasive
DrugsTrastuzumab emtansine·Pyrotinib·Pertuzumab·Trastuzumab
Shanghai Jiao Tong University School of Medicine
Phase 2
216
Shanghai
2020-05-30
Recruiting
Early De-escalation of Empirical Antibiotics Treatment for Neutropenic Fever
NCT04270786Safety Issues
Shanghai Jiao Tong University School of Medicine
Not applicable
200
Shanghai
2020-01-01
Recruiting
Overweight and Obesity and Puberty Development Cohort Study
NCT04113070Precocious Puberty, Overweight and Obesity
Shanghai Jiao Tong University School of Medicine
Observational
14,100
Shanghai
2019-10-11
Active, closed
Decreasing Risk of Psychosis by Sulforaphane (DROPS Trial)
NCT03932136Clinical High Risk Syndrome of Psychosis
Shanghai Jiao Tong University School of Medicine
Phase 3
300
Guangzhou, Zhengzhou, Changsha, Suzhou, Shanghai, Shenzhen, Tianjin
2019-07-14
Active, closed
Intensive Diet and Physical Activity on Diabetes
NCT03839667Type2 Diabetes, Life Style
Shanghai Jiao Tong University School of Medicine
Not applicable
326
Shanghai
2019-01-07
Recruiting
The Diabetic Retinopathy Screening, Prevention and Control Program
NCT04240652Diabetic Retinopathy
Shanghai Jiao Tong University School of Medicine
Observational
500,000
Shanghai
2018-06-05
Recruiting
Phage II Trial of Stathmin as Predictive Biomarker for TPF Induction Chemotherapy in OSCC
NCT03326947Neoplasm Neck
Shanghai Jiao Tong University School of Medicine
Phase 2
60
Shanghai
2018-01-01
Recruiting
Cyclin D1 Based TPF Induction Chemotherapy for Oral Squamous Cell Carcinoma Patients at Clinical N2 Stage
NCT02290145Mouth Neoplasms, Carcinoma, Squamous Cell
Shanghai Jiao Tong University School of Medicine
Phase 2
48
Shanghai
2016-12
Recruiting
A Randomised Trial of Cabazitaxel, Docetaxel, Mitoxantrone or Satraplatin (CDMS) Plus Surgery for Prostate Cancer Patients
NCT03258320Prostate Cancer Patients
Shanghai Jiao Tong University School of Medicine
Phase 2/3
300
Qingdao, Shanghai
2015-01
Recruiting
A Randomized Trial of Chemotherapy in Surgical Patients With Infiltrating Ductal Carcinoma of Breast
NCT02897700Breast Cancer
Shanghai Jiao Tong University School of Medicine
Phase 1
300
Ganzhou, Changchun, Shanghai
2013-01
Recruiting
Genetics of Obesity in Chinese Youngs
NCT01084967Obesity, Metabolic Syndrome
Shanghai Jiao Tong University School of Medicine
Observational
8,000
Shanghai
2009-03
Recruiting
A Randomised Trial of Chemotherapy Plus Surgery for Recurrent Non-Small Cell Lung Cancer
NCT02889666Recurrent Non-small Cell Lung Cancer
DrugsGemcitabine/Cisplatin·Docetaxel·Cisplatin·Carboplatin
Shanghai Jiao Tong University School of Medicine
Phase 1
500
Changchun, Shanghai
2008-01
Rows per page Showing 1–72 of 72
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Chinese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 26 September 2026. https://priyalifescience.com/clinical-trials-china/city/shanghai

Query this register directly
GET /api/trials?country=cn&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in China and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 19,052 studies in total at the last sync on 22 Sep 2026, 11:10 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 72 of those studies with a site in Shanghai that also match the filters currently applied.

How many clinical trials are recruiting in Shanghai?

48 of the 72 studies on this page are recruiting new participants as of the 22 Sep 2026, 11:10 UTC sync. A further 11 have not yet opened recruitment, 11 are active but closed to new participants, and 2 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Shanghai), 72 studies
PhaseStudiesRecruitingShare
Observational221530.6%
Phase 2151220.8%
Not applicable13518.1%
Phase EARLY_PHASE1658.3%
Phase 3546.9%
Phase 1324.2%
Phase 2/3334.2%
Phase 4324.2%
Phase 1/2202.8%

Most active sponsors

Lead sponsors with the most studies (Shanghai)
Lead sponsorStudiesRecruiting
Shanghai Jiao Tong University School of Medicine7248
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and India registers.